Cargando…

C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression

Detalles Bibliográficos
Autores principales:	O’Farrell, Courtney, Shamay, Meir, Kalu, Nene, Ambinder, Richard F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002743/ http://dx.doi.org/10.1186/1750-9378-5-S1-A8

Ejemplares similares

Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir
por: Shirley, Courtney M, et al.
Publicado: (2012)

ER stress activates lytic gene expression in KSHV-associated tumor cell lines
por: Kalu, Nene, et al.
Publicado: (2012)

Development of a proteomic platform for EBV and KSHV serological screening
por: Wang, Leyao, et al.
Publicado: (2010)

Contribution of the KSHV and EBV lytic cycles to tumourigenesis
por: Manners, Oliver, et al.
Publicado: (2018)

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009)

Relationship between salivary shedding and seropositivity for Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) among South African children and adults: insights on why EBV infection is ubiquitous and KSHV is not
por: Butler, Lisa, et al.
Publicado: (2010)

Regulation of C/EBPbeta1 by Ras in mammary epithelial cells and the role of C/EBPbeta1 in oncogene-induced senescence
por: Atwood, Allison A., et al.
Publicado: (2010)

Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
por: Beachler, Dan, et al.
Publicado: (2010)

Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy
por: Granato, Marisa, et al.
Publicado: (2017)

Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi’s Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells
por: Simpson, Sydney, et al.
Publicado: (2018)

KSHV RTA Abolishes NFκB Responsive Gene Expression during Lytic Reactivation by Targeting vFLIP for Degradation via the Proteasome
por: Ehrlich, Elana S., et al.
Publicado: (2014)

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

Cells Expressing the C/EBPbeta Isoform, LIP, Engulf Their Neighbors
por: Abreu, Maria, et al.
Publicado: (2012)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma
por: Cavallin, Lucas E, et al.
Publicado: (2010)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

KSHV interaction with Langerhans and dermal dendritic cells through C-type lectins
por: Rappocciolo, Giovanna, et al.
Publicado: (2010)

Negative Regulation of C/EBPbeta1 by Sumoylation in Breast Cancer Cells
por: Atwood, Allison A., et al.
Publicado: (2011)

The Prevalence of EBV and KSHV in Odontogenic Lesions
por: Alsaegh, Mohammed Amjed, et al.
Publicado: (2022)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

KSHV regulation of fibulins in Kaposi’s sarcoma: implications for tumorigenesis
por: Alcendor, Donald, et al.
Publicado: (2010)

C/EBPBeta and Elk-1 synergistically transactivate the c-fos serum response element
por: Hanlon, Mary, et al.
Publicado: (2000)

Epigenetic Analysis of KSHV Latent and Lytic Genomes
por: Toth, Zsolt, et al.
Publicado: (2010)

Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV
por: van Gent, Michiel, et al.
Publicado: (2021)

Inhibition of KSHV-associated lymphoma engraftment in SCID mouse by morpholino oligomers
por: Nan, Yuchen, et al.
Publicado: (2010)

Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
por: Linnstaedt, Sarah, et al.
Publicado: (2010)

Current epidemiology of KSHV infection in American men who have sex with men
por: Labo, Nazzarena, et al.
Publicado: (2010)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
por: Park, Mi-Kyung, et al.
Publicado: (2019)

Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma
por: Nayar, Utthara, et al.
Publicado: (2010)

Emerging Themes from EBV and KSHV microRNA Targets
por: Ramalingam, Dhivya, et al.
Publicado: (2012)

Coordination of KSHV Latent and Lytic Gene Control by CTCF-Cohesin Mediated Chromosome Conformation
por: Kang, Hyojeung, et al.
Publicado: (2011)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

The activation of KSHV lytic cycle blocks autophagy in PEL cells
por: Granato, Marisa, et al.
Publicado: (2015)

The landscape of transcription initiation across latent and lytic KSHV genomes
por: Ye, Xiang, et al.
Publicado: (2019)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

New bortezomib-based combination therapy for elimination of myeloma cells
por: Meister, S, et al.
Publicado: (2009)

CpG methylation as a tool to characterize cell-free Epstein-Barr virus DNA
por: Shamay, Meir, et al.
Publicado: (2012)

Viral Infection and Autophagy Dysregulation: The Case of HHV-6, EBV and KSHV
por: Romeo, Maria Anele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3m6use67074b3mgt2lmoqcuvnq